Home
LIXT
LIXT News

Latest Lixte Biotechnology Holdings Inc. (LIXT) News on October 22, 2025

LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

GlobeNewswire

6 days ago

LIXTE Biotechnology Holdings Highlights Q4 2025 Priorities, Including Ongoing Advancement of Lead Candidate LB-100, Strategic Oncology Business Development and Acquisition Plans

MT Newswires

a month ago

Lixte Biotechnology Buys $2.6 Million of Cryptocurrencies

LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions

GlobeNewswire

a month ago

LIXTE Biotechnology Holdings Makes $2.6 Million Initial Purchase of Digital Currency to Diversify Treasury and for Potential Acquisitions

LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100

GlobeNewswire

7 months ago

LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

GlobeNewswire

7 months ago

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form

GlobeNewswire

7 months ago

New Findings Show how LIXTE’s Lead Clinical Compound, LB-100, is Metabolized to its Active Form

LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

GlobeNewswire

8 months ago

LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

Lixte Biotechnology announces closing of $1.05M registered direct offering

TipRanks

8 months ago

Lixte Biotechnology announces closing of $1.05M registered direct offering

MT Newswires

8 months ago

Lixte Biotechnology Closes $1.1 Million Direct Offering

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

8 months ago

LIXTE Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire

8 months ago

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

GlobeNewswire

8 months ago

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

US Penny Stocks To Watch In December 2024

Simply Wall St.

10 months ago

US Penny Stocks To Watch In December 2024

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

ACCESSWIRE

a year ago

Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology

GlobeNewswire

a year ago

LIXTE Receives U.S. Patent Issue Notification for Immune Oncology

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

GlobeNewswire

a year ago

First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborating with NKI, Supported by Major Pharma Company

LIXTE Biotechnology Provides Update On Recent Activities and Developments

GlobeNewswire

a year ago

LIXTE Biotechnology Provides Update On Recent Activities and Developments

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

GlobeNewswire

a year ago

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

ACCESSWIRE

a year ago

Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

GlobeNewswire

a year ago

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial

GlobeNewswire

a year ago

LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Business Wire

a year ago

Net Asset Value(s)

Europe Antibody Drug Conjugates Market Forecast to 2030: Increasing Investments to Develop ADCs Fuels the European Antibody Drug Conjugates Market

GlobeNewswire

a year ago

Europe Antibody Drug Conjugates Market Forecast to 2030: Increasing Investments to Develop ADCs Fuels the European Antibody Drug Conjugates Market

Kenya Ecommerce Market Databook 2024-2028, Featuring Avechi, Jiji, Jumia, Kilimall, MyDawa, Bolt Food, Jumia Food, LetaFood, Yum Deliveries, Hava Net, Little Cab, Maramoja and Transport Wasili

GlobeNewswire

a year ago

Kenya Ecommerce Market Databook 2024-2028, Featuring Avechi, Jiji, Jumia, Kilimall, MyDawa, Bolt Food, Jumia Food, LetaFood, Yum Deliveries, Hava Net, Little Cab, Maramoja and Transport Wasili

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

PR Newswire

a year ago

Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than

UK's Sunak apologises for leaving D-Day ceremony early

AFP

a year ago

UK's Sunak apologises for leaving D-Day ceremony early

3 Major Product Releases at 3Shape Discover Event

PR Newswire

a year ago

3 Major Product Releases at 3Shape Discover Event

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%

GlobeNewswire

a year ago

Fiber Optic Sensors Global Market Forecast & Analysis 2023-2033: Global Fiber Optic Sensors Market to Reach $605.4 Million by 2032 with a CAGR of 6.2%

Millions of Chinese students start exams in biggest 'gaokao' ever

AFP

a year ago

Millions of Chinese students start exams in biggest 'gaokao' ever

Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System

GlobeNewswire

a year ago

Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System

LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer

GlobeNewswire

a year ago

LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer

LIXTE Biotechnology Holdings Provides Update on Recent Activities

GlobeNewswire

a year ago

LIXTE Biotechnology Holdings Provides Update on Recent Activities

LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”

GlobeNewswire

a year ago

LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”

MT Newswires

a year ago

Lixte Biotechnology Files Up to $50 Million Mixed Shelf

NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

GlobeNewswire

2 years ago

NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

GlobeNewswire

2 years ago

LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments

Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research

GlobeNewswire

2 years ago

Professor René Bernards to Present New Pre-Clinical Data on LIXTE’s LB-100 at Joint Conference of European and American Associations for Cancer Research

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

GlobeNewswire

2 years ago

LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI

Maris-Tech Announces Record Backlog of Approximately $10,800,000

GlobeNewswire

2 years ago

Maris-Tech Announces Record Backlog of Approximately $10,800,000

Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

GlobeNewswire

2 years ago

Akoustis Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial

GlobeNewswire

2 years ago

First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

GlobeNewswire

2 years ago

ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices

Akoustis Secures a wBMS Design Win with Tier-1 Automotive Product Supplier

GlobeNewswire

2 years ago

Akoustis Secures a wBMS Design Win with Tier-1 Automotive Product Supplier

Maris-Tech Receives New Order for approximately $590,000 for an AI-based HLS and Defense Surveillance Application

GlobeNewswire

2 years ago

Maris-Tech Receives New Order for approximately $590,000 for an AI-based HLS and Defense Surveillance Application

Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

PR Newswire

2 years ago

Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors

GlobeNewswire

2 years ago

MoneyHero Group Preannounces Record Breaking Year-Over-Year Growth, Outshining Competitors

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

GlobeNewswire

2 years ago

ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

Simply Wall St.

2 years ago

Why It Might Not Make Sense To Buy William Penn Bancorporation (NASDAQ:WMPN) For Its Upcoming Dividend

20 Countries with the Highest Plastic Surgery Rates per Capita

Insider Monkey

2 years ago

20 Countries with the Highest Plastic Surgery Rates per Capita

Greenwave Technology Solutions Commences Operation of Metal Baler, Wire Stripper, and Sheers at Non-Ferrous Processing Facility

PR Newswire

2 years ago

Greenwave Technology Solutions Commences Operation of Metal Baler, Wire Stripper, and Sheers at Non-Ferrous Processing Facility

Calculating The Intrinsic Value Of Rent the Runway, Inc. (NASDAQ:RENT)

Simply Wall St.

2 years ago

Calculating The Intrinsic Value Of Rent the Runway, Inc. (NASDAQ:RENT)

Maris-Tech Announces Preliminary Gross Revenue Projection For 2024 in Excess of $7,000,000

GlobeNewswire

2 years ago

Maris-Tech Announces Preliminary Gross Revenue Projection For 2024 in Excess of $7,000,000

Renting Clothes Was Supposed to Be the Future of Fashion. Then Shoppers Got Bored.

The Wall Street Journal

2 years ago

Renting Clothes Was Supposed to Be the Future of Fashion. Then Shoppers Got Bored.

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

GlobeNewswire

2 years ago

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary Oral Medical Devices to Treat Severe OSA

Here's What Profire Energy's (NASDAQ:PFIE) Strong Returns On Capital Mean

Simply Wall St.

2 years ago

Here's What Profire Energy's (NASDAQ:PFIE) Strong Returns On Capital Mean

Comstock Acquires Development Site in Rockville, MD

Business Wire

2 years ago

Comstock Acquires Development Site in Rockville, MD

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

GlobeNewswire

2 years ago

Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished

Greenwave Technology Solutions' Scrap App Expands to Second Market as it Continues to Capture Market Share

PR Newswire

2 years ago

Greenwave Technology Solutions' Scrap App Expands to Second Market as it Continues to Capture Market Share

ENGlobal Regains Compliance with Nasdaq Minimum Bid Price Requirement

ACCESSWIRE

2 years ago

ENGlobal Regains Compliance with Nasdaq Minimum Bid Price Requirement

Genius Group Pays in Full $18.13 Million of Convertible Notes

GlobeNewswire

2 years ago

Genius Group Pays in Full $18.13 Million of Convertible Notes

Genius Group Provides Updated Guidance, with Profitable 2023 on 43% to 60% Revenue Growth.

GlobeNewswire

2 years ago

Genius Group Provides Updated Guidance, with Profitable 2023 on 43% to 60% Revenue Growth.

PR Newswire

2 years ago

SingSaver is Singapore's largest one-stop finance comparison platform to compare 43 travel insurance products

Genius Group Launches AI Education Ecosystem in Partnership with FatBrain AI

GlobeNewswire

2 years ago

Genius Group Launches AI Education Ecosystem in Partnership with FatBrain AI

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

GlobeNewswire

2 years ago

Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now

MoneyHero Group Reports Third Quarter 2023 Results

GlobeNewswire

2 years ago

MoneyHero Group Reports Third Quarter 2023 Results

Strategic Leadership Transition at HUB Security: Noah Hershcoviz Appointed CEO while Uzi Moscovich Assumes back an Active Director Role

GlobeNewswire

2 years ago

Strategic Leadership Transition at HUB Security: Noah Hershcoviz Appointed CEO while Uzi Moscovich Assumes back an Active Director Role

PR Newswire

2 years ago

Prestige Wealth Inc. Announces First Half of Fiscal Year 2023 Financial Results

urban-gro, Inc. Awarded $9.6 Million Industrial Design-Build Contract with Existing CPG Client

GlobeNewswire

2 years ago

urban-gro, Inc. Awarded $9.6 Million Industrial Design-Build Contract with Existing CPG Client

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

ACCESSWIRE

2 years ago

Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023

ENGlobal Announces Reverse Stock Split, Nasdaq Communication Regarding Stockholders' Equity

ACCESSWIRE

2 years ago

ENGlobal Announces Reverse Stock Split, Nasdaq Communication Regarding Stockholders' Equity

Dario Contracts with New Employer for Cardiometabolic Solution

PR Newswire

2 years ago

Dario Contracts with New Employer for Cardiometabolic Solution

Activist group boosts its offer to buy New York-based Carver

American Banker

2 years ago

Activist group boosts its offer to buy New York-based Carver

Foresight Announces Third Quarter 2023 Financial Results

News Direct

2 years ago

Foresight Announces Third Quarter 2023 Financial Results

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Remark Holdings, Inc. (NASDAQ:MARK) Q3 2023 Earnings Call Transcript

PR Newswire

2 years ago

Dream Chasers raises its offer to $3.25 per share for 35% of Nasdaq listed Carver Bancorp symbol: CARV

Wheeler Considers Calling a Special Meeting of Stockholders

ACCESSWIRE

2 years ago

Wheeler Considers Calling a Special Meeting of Stockholders

The Top 3 Most Promising Energy Penny Stocks to Buy

InvestorPlace

2 years ago

The Top 3 Most Promising Energy Penny Stocks to Buy

180 Degree Capital Corp. Establishes Discount Management Program And Reports Net Asset Value Per Share (“Nav”) Of $4.91, Comprised Of 97% Cash And Public Securities, As Of September 30, 2023

GlobeNewswire

2 years ago

180 Degree Capital Corp. Establishes Discount Management Program And Reports Net Asset Value Per Share (“Nav”) Of $4.91, Comprised Of 97% Cash And Public Securities, As Of September 30, 2023

LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations

GlobeNewswire

2 years ago

LIXTE Biotechnology Provides Update on Clinical Progress and Expanding Collaborations

FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease

PR Newswire

2 years ago

FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

GlobeNewswire

2 years ago

Aprea Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Business Update

Flux Power Fiscal Year 2024 First Quarter Financial Results

Business Wire

2 years ago

Flux Power Fiscal Year 2024 First Quarter Financial Results

Comstock Reports Third Quarter 2023 Results

Business Wire

2 years ago

Comstock Reports Third Quarter 2023 Results

Vroom, Inc. (NASDAQ:VRM) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Vroom, Inc. (NASDAQ:VRM) Q3 2023 Earnings Call Transcript

Zacks Small Cap Research

2 years ago

PLX: More Regulatory Approvals

ATA Creativity Global Schedules 2023 Third Quarter Financial Results Release and Conference Call

GlobeNewswire

2 years ago

ATA Creativity Global Schedules 2023 Third Quarter Financial Results Release and Conference Call

Protalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Results

GuruFocus.com

2 years ago

Protalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Results

Carver Bancorp, Inc. Interim CEO Craig C. MacKay Provides Strategic Update on the Bank's Progress and Impact on the Communities it Serves

PR Newswire

2 years ago

Carver Bancorp, Inc. Interim CEO Craig C. MacKay Provides Strategic Update on the Bank's Progress and Impact on the Communities it Serves

Warrantee Inc. Announces Receipt of Nasdaq Delisting Determination; Plans to Appeal

GlobeNewswire

2 years ago

Warrantee Inc. Announces Receipt of Nasdaq Delisting Determination; Plans to Appeal

Cohen & Company Reports Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Cohen & Company Reports Third Quarter 2023 Financial Results

Forian Inc. to Participate in the 12th Annual ROTH MKM Technology Event

GlobeNewswire

2 years ago

Forian Inc. to Participate in the 12th Annual ROTH MKM Technology Event

Share on Social Networks: